Emerging findings suggest that Retatrutide , a dual activator targeting GLP-1 and gastric inhibitory peptide receptors , appears to be a turning point within weight management . Early human trials https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026